Bertrand Rochat

Fully-automated systems and the need for global approaches should exhort clinical labs to reinvent routine MS analysis?

Bertrand Rochat, B. Rochat, 2018, Bioanalysis.

A Close Look at the Fate of Compounds we are Exposed to.

Bertrand Rochat, Julia Bilat, Baptiste Grund, 2014, Chimia.

The future key role of LC-high-resolution-MS analyses in clinical laboratories: a focus on quantification.

Bertrand Rochat, Emmanuel Kottelat, Justin McMullen, 2012, Bioanalysis.

From targeted quantification to untargeted metabolomics: Why LC-high-resolution-MS will become a key instrument in clinical labs

Bertrand Rochat, B. Rochat, 2016 .

Comparison between a high-resolution single-stage Orbitrap and a triple quadrupole mass spectrometer for quantitative analyses of drugs.

Hugues Henry, Bertrand Rochat, B. Rochat, 2012, Rapid communications in mass spectrometry : RCM.

Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein.

Nicolas Widmer, Serge Leyvraz, Bertrand Rochat, 2006, British journal of clinical pharmacology.

In vitro biotransformation of imatinib by the tumor expressed CYP1A1 and CYP1B1

Aurélien Grosdidier, Olivier Michielin, Vincent Zoete, 2008, Biopharmaceutics & drug disposition.

Ultra-high pressure liquid chromatography-mass spectrometry for plant metabolomics: a systematic comparison of high-resolution quadrupole-time-of-flight and single stage Orbitrap mass spectrometers.

Jean-Luc Wolfender, Bertrand Rochat, G. Glauser, 2013, Journal of chromatography. A.

Proposed Confidence Scale and ID Score in the Identification of Known-Unknown Compounds Using High Resolution MS Data

Bertrand Rochat, B. Rochat, 2017, Journal of The American Society for Mass Spectrometry.